JIR
GILD icon

James Investment Research’s Gilead Sciences GILD Stock Holding History

James Investment Research’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33
Closed -$3K – 369
2023
Q1 		$3K Buy
+33
New +$2.73K ﹤0.01% 515
2019
Q3 		– Sell
-500
Closed -$34K – 595
2019
Q2 		$34K Buy
500
+100
+25% +$6.58K ﹤0.01% 531
2019
Q1 		$26K Sell
400
-10,741
-96% -$714K ﹤0.01% 685
2018
Q4 		$697K Sell
11,141
-38,794
-78% -$2.71M 0.04% 436
2018
Q3 		$3.86M Buy
49,935
+30,157
+152% +$2.28M 0.16% 124
2018
Q2 		$1.4M Sell
19,778
-35,883
-64% -$2.53M 0.05% 450
2018
Q1 		$4.2M Buy
55,661
+15,137
+37% +$1.2M 0.16% 133
2017
Q4 		$2.9M Buy
40,524
+7,644
+23% +$580K 0.1% 174
2017
Q3 		$2.66M Buy
32,880
+32,700
+18,167% +$2.5M 0.09% 181
2017
Q2 		$13K Hold
180
– – ﹤0.01% 681
2017
Q1 		$12K Buy
+180
New +$12.7K ﹤0.01% 622

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

James Investment Research's GILD Position: Q2 2023 in Review

James Investment Research sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 33 shares — an estimated $3K sold.

James Investment Research first reported a position in GILD in Q1 2017 and held it in 11 quarters. The position peaked at $4.2M in Q1 2018. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • James Investment Research reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 33 Gilead Sciences shares in Q2 2023, an estimated $3K.
  • James Investment Research first reported a position in Gilead Sciences in Q1 2017 and held it in 11 quarters.
  • James Investment Research's Gilead Sciences position peaked at $4.2M in Q1 2018.
  • 1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.